| (84) |
Designated Contracting States: |
|
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
Designated Extension States: |
|
AL LT LV SI |
| (30) |
Priority: |
04.07.1995 DK 78295
|
| (43) |
Date of publication of application: |
|
21.05.2003 Bulletin 2003/21 |
| (62) |
Application number of the earlier application in accordance with Art. 76 EPC: |
|
96925654.4 / 0836648 |
| (73) |
Proprietor: GSF Forschungszentrum für Umwelt und Gesundheit
GMBH |
|
85764 Oberschleissheim (DE) |
|
| (72) |
Inventors: |
|
- Sutter, Gerd
80802 München (DE)
- Ohlmann, Marion
81927 München (DE)
- Erfle, Volker
81679 München (DE)
|
| (74) |
Representative: Pielken, Petra |
|
Bavarian Nordic GmbH,
Fraunhoferstrasse 18 b
82152 Martinsried
82152 Martinsried (DE) |
| (56) |
References cited: :
|
| |
|
|
- WÖLFEL T ET AL: "TWO TYROSINASE NONAPEPTIDES RECOGNIZED ON HLA-A2 MELANOMAS BY AUTOLOGOUS
CYTOLYTIC T LYMPHOCYTES" EUROPEAN JOURNAL OF IMMUNOLOGY, WEINHEIM, DE, vol. 24, 1994,
pages 759-764, XP000571867 ISSN: 0014-2980
- JIMBOW K ET AL: "COORDINATED MRNA AND PROTEIN EXPRESSION OF HUMAN LAMP-1 IN INDUCTION
OF MELANGOGENESIS AFTER UV-B EXPOSURE AND CO-TRANSFECTIONOF HUMAN TYROSINASE AND TRP-1
CDNAS" PIGMENT CELL RESEARCH, COPENHAGEN, DK, vol. 7, no. 5, October 1994 (1994-10),
pages 311-319, XP000953012 ISSN: 0906-9305
- G.SUTTER ET AL.: "A recombinant vector derived from the host range-restricted and
highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice
to influenza virus" VACCINE, vol. 12, no. 11, August 1994 (1994-08), pages 1032-1040,
XP002019163 GUILDFORD GB
- DREXLER I ET AL: "Modified vaccinia virus Ankara for delivery of human tyrosinase
as melanoma-associated antigen: Induction of tyrosinase- and melanoma-specific human
leukocyte antigen A*0201-restricted cytotoxic T-cells in vitro and in vivo" CANCER
RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, US, vol. 59, 1
October 1999 (1999-10-01), pages 4955-4963, XP002185047 ISSN: 0008-5472
|
|
